Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-01-25 @ 1:51 AM
Study NCT ID:
NCT04113018
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-23
First Post:
2019-09-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
Sponsor:
Wake Forest University Health Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-10
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-27
First Submit QC Date:
None
Study First Post Date:
2019-10-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-24
Results First Submit QC Date:
None
Results First Post Date:
2024-07-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-21
Last Update Post Date:
2025-07-23
Last Update Post Date Type:
ACTUAL